Creatine Safety and Tolerability in Premanifest HD: PRECREST

Clinical trial NCT00592995 · COMPLETED

Trial details

NCT number: NCT00592995
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2007-12-01
Primary completion: 2012-09-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.